Arnon named first woman to lead Israel Academy of Sciences

Prof. Binyamin Ze’ev Kedar appointed to serve as academy’s vice president.

By
June 22, 2010 04:28
1 minute read.
The Jerusalem Post

Lab 311. (photo credit: Bloomberg)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

World-renowned immunologist Prof. Ruth Arnon of the Weizmann Institute has been named the new – and first woman – president of the Israel Academy of Sciences and the Humanities, since 1961 the government’s official adviser on science and planning of civilian research.

She replaces Prof. Menahem Ya’ari, who held the position for two three-year terms.

Be the first to know - Join our Facebook page.


The academy also announced on Monday that Arnon’s vice president will be Prof.

Binyamin Ze’ev Kedar. Both were elected at a general assembly of 100 academy members, and they will take office around Rosh Hashana. The social sciences and humanities are represented in the academy along with the exact sciences.

Arnon, whom The Jerusalem Post chose a few weeks ago as one of the “50 most influential Jews in the world,” is the co-developer of the Teva drug Copaxone for reducing the frequency and severity of multiple sclerosis attacks.

This was the first original Israeli drug, and it is now taken by many MS patients around the world.

She is also a member of the European Molecular Biology Organization and was president of the European Federation of Immunological Societies, as well as the recipient of numerous prestigious awards, including the Robert Koch Prize, Israel Prize, Rothschild Prize, Hadassah Women’s Zionist Organization of American’s Women of Achievement Prize and honorary doctorates.



Prof. Kedar is a Hebrew University historian and an expert in the Crusader period.

He is chairman of the council of the Israel Antiquities Authority, a member of the Medieval Academy of America and founding editor of the journal Crusades.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia

By UNIVERSITY OF MICHIGAN HEALTH SYSTEM